Shl Telemedicine Ltd Stock Today
SHLT Stock | 2.60 0.10 4.00% |
PerformanceVery Weak
| Odds Of DistressQuite High
|
SHL Telemedicine is selling for under 2.60 as of the 20th of March 2025; that is 4.00 percent up since the beginning of the trading day. The stock's last reported lowest price was 2.3. SHL Telemedicine has more than 62 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 3rd of April 2023 | Category Healthcare | Classification Health Care |
SHL Telemedicine is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 16.39 M outstanding shares of which 5.51 K shares are at this time shorted by private and institutional investors with about 1.98 trading days to cover. More on SHL Telemedicine Ltd
Moving together with SHL Stock
Moving against SHL Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
SHL Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Care Facilities, Healthcare (View all Sectors) | ||||
Average Analyst Recommendation | |||||
SHL Telemedicine can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand SHL Telemedicine's financial leverage. It provides some insight into what part of SHL Telemedicine's total assets is financed by creditors.
|
SHL Telemedicine Ltd (SHLT) is traded on NASDAQ Exchange in USA. It is located in Ashdar Building, Tel Aviv, Israel, 6789130 and employs 583 people. SHL Telemedicine is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 43.89 M. SHL Telemedicine conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 16.39 M outstanding shares of which 5.51 K shares are at this time shorted by private and institutional investors with about 1.98 trading days to cover.
SHL Telemedicine generates negative cash flow from operations
Check SHL Telemedicine Probability Of Bankruptcy
Ownership AllocationSHL Telemedicine shows a total of 16.39 Million outstanding shares. SHL Telemedicine has 8.3 % of its outstanding shares held by insiders and 21.8 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check SHL Ownership Details
SHL Telemedicine Historical Income Statement
SHL Stock Against Markets
SHL Telemedicine Corporate Management
Erez Nachtomy | Chief Officer | Profile | |
Amir Hai | Chief Officer | Profile | |
Lior Haalman | Chief Officer | Profile | |
Bernd Altpeter | CoManaging Germany | Profile | |
Linus Drop | CoManaging Germany | Profile | |
David Arnon | Chief Officer | Profile |
Additional Tools for SHL Stock Analysis
When running SHL Telemedicine's price analysis, check to measure SHL Telemedicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SHL Telemedicine is operating at the current time. Most of SHL Telemedicine's value examination focuses on studying past and present price action to predict the probability of SHL Telemedicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SHL Telemedicine's price. Additionally, you may evaluate how the addition of SHL Telemedicine to your portfolios can decrease your overall portfolio volatility.